Search by Drug Name or NDC
NDC 75920-0464-04 Blowfish 500; 60 mg/1; mg/1 Details
Blowfish 500; 60 mg/1; mg/1
Blowfish is a ORAL TABLET, EFFERVESCENT in the HUMAN OTC DRUG category. It is labeled and distributed by Rally Labs LLC. The primary component is ASPIRIN; CAFFEINE.
Product Information
| NDC | 75920-0464 |
|---|---|
| Product ID | 75920-0464_0daa059c-59cd-268d-e063-6294a90a0c61 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Blowfish |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Aspirin, Caffeine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, EFFERVESCENT |
| Route | ORAL |
| Active Ingredient Strength | 500; 60 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | ASPIRIN; CAFFEINE |
| Labeler Name | Rally Labs LLC |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M013 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 75920-0464-04 (75920046404)
| NDC Package Code | 75920-0464-4 |
|---|---|
| Billing NDC | 75920046404 |
| Package | 40 TABLET, EFFERVESCENT in 1 BAG (75920-0464-4) |
| Marketing Start Date | 2017-11-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |